DOI QR코드

DOI QR Code

Management of Blood Glucose in Diabetes Mellitus Using Modified Jawonjihwang-tang: A Retrospective Case Series of 76 Patients

자원지황탕을 활용한 당뇨병 혈당 관리 치료 76례에 대한 관찰 연구

  • Jeong, Yong-wook (Jega Medical Clinic of Korean Medicine) ;
  • Jeon, Sang-woo (Dept. of Internal Medicine, College of Korean Medicine, Woo-Suk University) ;
  • Lee, Gi-hyang (Dept. of Internal Medicine, College of Korean Medicine, Woo-Suk University) ;
  • Kang, Su-bin (Dept. of Neuropsychiatry, College of Korean Medicine, Woo-Suk University) ;
  • Jeong, Min-jeong (Dept. of Pediatrics, College of Korean Medicine, Woo-Suk University) ;
  • Kim, Hong-jun (Dept. of Prescription, College of Korean Medicine, Woo-Suk University) ;
  • Jang, In-soo (Dept. of Internal Medicine, College of Korean Medicine, Woo-Suk University)
  • 정용욱 (제가한의원) ;
  • 전상우 (우석대학교 한의과대학 내과학교실) ;
  • 이기향 (우석대학교 한의과대학 내과학교실) ;
  • 강수빈 (우석대학교 한의과대학 신경정신과학교실) ;
  • 정민정 (우석대학교 한의과대학 소아과학교실) ;
  • 김홍준 (우석대학교 한의과대학 방제학교실) ;
  • 장인수 (우석대학교 한의과대학 내과학교실)
  • Received : 2019.12.06
  • Accepted : 2020.01.08
  • Published : 2019.12.30

Abstract

Objectives: The purpose of this study was to evaluate the effectiveness of the management of blood glucose in diabetes mellitus using modified Jawonjihwang-tang in a Korean medical clinic, retrospectively. Methods: From 2006 to 2018, 150 patients diagnosed with diabetes who visited a Korean medical clinic were treated with Korean medicine. Then, 81 of them were prescribed Jawonjihwang-tang. Five cases who changed the formula during the procedure were excluded; therefore, 76 cases were finally selected. Their therapeutic effects were evaluated by the variance in glycated hemoglobin (HbA1c). Results: After administration of Jawonjihwang-tang, most patients exhibited a decreased level of HbA1c, and 24 patients had normalized the level of HbA1c. The HbA1c level of all patients decreased from 9.1±2.2 to 7.8±2.2 significantly (p<0.001). Conclusions: It is concluded that Jawonjihwang-tang may control blood glucose in diabetes patients. However, more prospective randomized clinical trials are warranted to verify this conclusion.

Keywords

References

  1. Korean diabetes association. Diabetes fact sheet in Korea 2018. May 14 2018. http://www.diabetes.or.kr/pro/news/admin.php?category=A&code=admin&number=1546&mode=view.
  2. Shin HY, Lee JY, Kim JE, Lee SM, Yoon HJ, Kim HR, et al. Cause-of-death statistics in 2016 in the Republic of Korea. J Korean Med Assoc 2018;61(9):573-84. https://doi.org/10.5124/jkma.2018.61.9.573
  3. Kim DH, Park SH, Lee JH, Lee HY, Cho MK, Cho JY, et al. Recent research trends in Korean medicine treatment of diabetes mellitus-focusing on domestic articles from 2008 to 2013. J Int Korean Med 2013;34(3):240-55.
  4. Gallagher EJ, Le RD, Bloomgarden Z. Review of hemoglobin A(1c) in the management of diabetes. J Diabetes 2009;1(1):9-17. https://doi.org/10.1111/j.1753-0407.2009.00009.x
  5. Diabetes guideline committee. Treatment guideline for diabetes 2019. Seoul: Korean diabetes association;2019, p. 1-86.
  6. UKPDS Group. UK prospective diabetes study 7: response of fasting plasma glucose to diet therapy in newly presenting type II diabetic patients. Metabolism 1990;39(9):905-12. https://doi.org/10.1016/0026-0495(90)90299-R
  7. Park TS, Baek HS, Park JH, General principles for diabetes mellitus management. J Korean Med Assoc 2008;51(9):806-12. https://doi.org/10.5124/jkma.2008.51.9.806
  8. Jeon JY, Kim DJ. Glycemic targets in patients with diabetes. J Korean Med Assoc 2017;60(11):889-92. https://doi.org/10.5124/jkma.2017.60.11.889
  9. Murata GH, Shah JH, Hoffman RM, Wendel CS, Adam KD, Solvas PA, et al. Intensified blood glucose monitoring improves glycemic control in stable, insulin-treated veterans with type 2 diabetes: the diabetes outcomes in veterans study (DOVES). Diabetes care 2003;26(6):1759-822. https://doi.org/10.2337/diacare.26.6.1759
  10. Duckworth WC, Abraira C, Moritz TE, Davis SN, Emanuele N, Goldman S, et al. The duration of diabetes affects the response to intensive glucose control in type 2 subjects: the VA diabetes trial. J Diabetes Complications 2011;25(6):355-61. https://doi.org/10.1016/j.jdiacomp.2011.10.003
  11. Kim GY, Park JB, Kim BW. Short-term Glycemic control and the related factor in association with compliance in diabetic patient. Journal of Preventive Medicine and Public Health 2000;33(3):349-63.
  12. Kim SA, Kang HY, Park WS, Ohrr HC, Song JS, Yi SW, et al. Prevalence and management status of diabetes mellitus in Korea. Korean J Med 2005;68(1):10-17.
  13. Cho NH. Prevalence of diabetes and management status in Korean population. Korean J Med 2005;68(1):1-3.
  14. Pu R, Geng XN, Yu F, Liang HG, Shi LW. Liuwei dihuang pills (六味地黄丸) enhance the effect of western medicine in treating type 2 diabetes: a meta-analysis of randomized controlled trials. Chin J Integr Med 2013;19(10):783-874. https://doi.org/10.1007/s11655-013-1591-7
  15. Lin L, Ni Q, Pang JL, Wei JP, Su CL, Yan XF. Therapeutic efficacy evaluation by a randomized controlled clinical research on traditional Chinese medical formulas, with herb modification according to syndrome differentiation in the treatment of 200 type 2 diabetic patients. Journal of Medical Research 2013;42(2):102-7.
  16. Xie W, Zhao Y, Zhang Y. Traditional Chinese medicines in treatment of patients with type 2 diabetes mellitus. Evid Based Complement Alternat Med 2011;2011:726723.
  17. Park SH. Study on change of the pattern identification of diabetes mellitus in Chinese traditional medicine recently - search Chinese traditional medical papers from 2003-2010. Journal of physiology &pathology in Korean Medicine 2011;25(2):176-84.
  18. Kim YH. Cheongganguigam. Gyeonggi-do: Seongbosa; 2001, p. 339.
  19. Mugabo Y, Zhao S, Seifried A, Gezzar S, AlMass A, Zhang D, et al. Identification of a mammalian glycerol-3-phosphate phosphatase: Role in metabolism and signaling in pancreatic beta-cells and hepatocytes. Proc Natl Acad Sci USA 2016;113(4):430-9.
  20. Zhao S, Mugabo Y, Ballentine G, Attane C, Iglesias J, Poursharifi P, et al. Alpha/beta-hydrolase domain 6 deletion induces adipose browning and prevents obesity and type 2 diabetes. Cell Rep 2016;14(12):2872-88. https://doi.org/10.1016/j.celrep.2016.02.076
  21. Ying B, Ruyuan Z, Yimiao T, Rui L, Beibei C, Hao Z, et al. Catalpol in diabetes and its complications: a review of pharmacology, pharmacokinetics, and safety. Molecules 2019;24(18):3302. https://doi.org/10.3390/molecules24183302
  22. Choi KS. Effects of coated liposome from discorea rhizoma extract (DRE) on hypoglycemic, serum insulin, and lipid levels in streptozotocin-induced. Korean J Food & Natr 2013;26(2):310-7. https://doi.org/10.9799/ksfan.2013.26.2.310
  23. Kim OK. Antidiabetic and antioxidative effects of corni fructus in streptozotocin-induced diabetic rats. JKOCS 2005;22(2):157-67.
  24. Huang YQ, Yang QF, Wang H, Xu YS, Peng W, Jiang YH. Long-term clinical effect of Tangyiping granules on patients with impaired glucose tolerance Chin J Integr Med 2016;22(9):653-9. https://doi.org/10.1007/s11655-016-2512-3